Dr. med. Tobias Krickau

Department of Paediatrics and Adolescent Medicine

CD40 blockade hampers IgG class-switch while enhancing Granzyme B production by transitional B cells (2025) Werner F, Wittner J, Lehmann C, Wahlbuhl-Becker M, Allabauer I, Hoffmann A, Schnell A, et al. Journal article FDG-PET/CT as a useful tool for disease activity assessment in large vessel vasculitis in childhood (2025) Krickau T, Atzinger A, Jüngert JM, Rech J, Rompel O, Hörning A Journal article, Letter Oral health status in children with chronic kidney disease, kidney transplantation, and nephrotic syndrome: a cross-sectional study (2025) Beyer A, Ebach F, Reutter HM, Sauerstein K, Hilger A, Krickau T, Tzschoppe A, et al. Journal article CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis (2024) Krickau T, Naumann-Bartsch N, Aigner M, Kharboutli S, Kretschmann S, Spörl S, Vasova I, et al. Journal article Patient Experiences and Challenges in the Management of Autoinflammatory Diseases—Data from the International FMF & AID Global Association Survey (2024) Rech J, Schett G, Tufan A, Kuemmerle-Deschner JB, Özen S, Tascilar K, Geck L, et al. Journal article Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry (2024) Kuemmerle-Deschner JB, Kallinich T, Henes J, Kortus-Götze B, Oommen PT, Rech J, Krickau T, et al. Journal article, Original article CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series (2024) Auth J, Müller F, Völkl S, Bayerl N, Distler JH, Tur C, Raimondo MG, et al. Journal article Severe bullous pemphigoid in a 4-month-old infant (2024) Holtsche MM, van Beek N, Vorobyev A, Schmidt E, Lauten M, Wagner N, Krickau T, Anemüller W Journal article "Multisystem Inflammatory Syndrome in Children"-Like Disease after COVID-19 Vaccination (MIS-V) with Potential Significance of Functional Active Autoantibodies Targeting G-Protein-Coupled Receptors (GPCR-fAAb) for Pathophysiology and Therapy. (2023) Schmidt M, Hébert S, Wallukat G, Ponader R, Krickau T, Galiano M, Reutter HM, et al. Journal article 3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) - Data from the RELIANCE Registry (2022) Kuemmerle-Deschner JB, Kortus-Goetze B, Oommen PT, Janda A, Rech J, Schuetz C, Kallinich T, et al. Conference contribution